{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:56:32Z","timestamp":1788054992255,"version":"build-2784847793"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["C06 RR15482"],"award-info":[{"award-number":["C06 RR15482"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jconrel.2023.12.008","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T06:57:54Z","timestamp":1702969074000},"page":"936-949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Assessment of antibiotic release and antibacterial efficacy from pendant glutathione hydrogels using ex vivo porcine skin"],"prefix":"10.1016","volume":"365","author":[{"given":"Angeliki","family":"Andrianopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Sokolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wenzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackery P.","family":"Bulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Gemeinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.12.008_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/clinpract11010011","article-title":"A structured approach to skin and soft tissue infections (SSTIs) in an ambulatory setting","volume":"11","author":"Silverberg","year":"2021","journal-title":"Clin. Pract."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0010","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1093\/cid\/ciz002","article-title":"Current epidemiology, etiology, and burden of acute skin infections in the United States","volume":"68","author":"Kaye","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13017-018-0219-9","article-title":"2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections","volume":"13","author":"Sartelli","year":"2018","journal-title":"World J. Emerg. Surg."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejpb.2018.02.022","article-title":"Recent advances on antimicrobial wound dressing: A review","volume":"127","author":"Simoes","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0025","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00134-016-4576-0","article-title":"Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review","volume":"42","author":"Burnham","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206893","article-title":"Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012","volume":"13","author":"Tun","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s40801-020-00196-6","article-title":"Expediting discharge in hospitalized, adult patients with skin and soft tissue infections who received empiric vancomycin therapy with oritavancin: description of findings from an institutional pathway","volume":"7","author":"Whittaker","year":"2020","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0040","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0045","first-page":"287","article-title":"Evaluation of physician prescribing patterns for antibiotics in the treatment of nonnecrotizing skin and soft tissue infections","volume":"43","author":"Ezebuenyi","year":"2018","journal-title":"P T"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2008\/846453","article-title":"Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care","volume":"19","author":"Ki","year":"2008","journal-title":"Can J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1185\/03007990903512057","article-title":"The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid","volume":"26","author":"Stein","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/tcrm.2006.2.4.401","article-title":"Meropenem in the treatment of complicated skin and soft tissue infections","volume":"2","author":"Fish","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CMR.00092-12","article-title":"Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents","volume":"26","author":"Gonzalez","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cts.12448","article-title":"Importance of drug pharmacokinetics at the site of action","volume":"10","author":"Rizk","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0075","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.clinthera.2016.06.015","article-title":"Pharmacokinetic and Pharmacodynamic principles of anti-infective dosing","volume":"38","author":"Onufrak","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0080","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.45.6.1843-1846.2001","article-title":"Pharmacokinetics and tissue penetration of linezolid following multiple oral doses","volume":"45","author":"Gee","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0085","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/jac\/dkv074","article-title":"Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections","volume":"70","author":"Hamada","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0090","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/ijerph10094274","article-title":"Strategies to minimize antibiotic resistance","volume":"10","author":"Lee","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0095","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/QCO.0000000000000044","article-title":"When antibiotics can be avoided in skin inflammation and bacterial colonization: a review of topical treatments","volume":"27","author":"Cooke","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"2014","key":"10.1016\/j.jconrel.2023.12.008_bb0110","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0115","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2147\/IJN.S154748","article-title":"Antimicrobial hydrogels: promising materials for medical application","volume":"13","author":"Yang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1534734618757532","article-title":"Local antibiotic delivery systems: current and future applications for diabetic foot infections","volume":"17","author":"Markakis","year":"2018","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0125","series-title":"Burn Surgery","article-title":"Topical agents and dressings for local burn wound care","author":"Tenenhaus","year":"2023"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0130","first-page":"182","article-title":"Wound dressing products: A translational investigation from the bench to the market","volume":"3","author":"Laurano","year":"2022","journal-title":"Eng. Regener."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fbioe.2020.00182","article-title":"Selection of appropriate wound dressing for various wounds","volume":"8","author":"Shi","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081169","article-title":"Advanced hydrogels as wound dressings","volume":"10","author":"Tavakoli","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/IDR.S396990","article-title":"Medical applications of hydrogels in skin infections: A review","volume":"16","author":"Teng","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2013.06.023","article-title":"Proteolytically activated anti-bacterial hydrogel microspheres","volume":"171","author":"Buhrman","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0160","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/btpr.1784","article-title":"Active, soluble recombinant melittin purified by extracting insoluble lysate of Escherichia coli without denaturation","volume":"29","author":"Buhrman","year":"2013","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1472-6750-12-63","article-title":"In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins","volume":"12","author":"Buhrman","year":"2012","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejps.2014.09.012","article-title":"Melittin-glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity","volume":"65","author":"Rayahin","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/qua.560480709","article-title":"Electrostatic properties of glutathione: A quantum molecular study","volume":"48","author":"Broch","year":"1993","journal-title":"Int. J. Quantum Chem."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0180","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s11095-021-03057-1","article-title":"Glutathione-conjugated hydrogels: flexible vehicles for personalized treatment of bacterial infections","volume":"38","author":"Sokolowski","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features","volume":"21","author":"Cong","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0190","first-page":"2474","article-title":"Management of Staphylococcus aureus infections","volume":"72","author":"Bamberger","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0195","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","article-title":"Meropenem: a review of its use in the treatment of serious bacterial infections","volume":"68","author":"Baldwin","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01415-17","article-title":"FDA-CDC antimicrobial resistance isolate Bank: a publicly available resource to support research, development, and regulatory requirements","volume":"56","author":"Lutgring","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0205","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0210","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/wrr.12074","article-title":"Development of a novel ex vivo porcine skin explant model for the assessment of mature bacterial biofilms","volume":"21","author":"Yang","year":"2013","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/iwj.12619","article-title":"A surfactant-based wound dressing can reduce bacterial biofilms in a porcine skin explant model","volume":"14","author":"Yang","year":"2017","journal-title":"Int. Wound J."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0220","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ja.2010.113","article-title":"A new assay to determine Oritavancin concentrations","volume":"63","author":"Vidaillac","year":"2010","journal-title":"J. Antibiot."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0225","first-page":"79","article-title":"Adipose tissue density, estimated adipose lipid fraction and whole body adiposity in male cadavers","volume":"18","author":"Martin","year":"1994","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tox.2013.07.009","article-title":"PopGen: A virtual human population generator","volume":"315","author":"McNally","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0240","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fphar.2020.00997","article-title":"Application of pharmacokinetic-Pharmacodynamic modeling in drug delivery: development and challenges","volume":"11","author":"Zou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0245","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1208\/s12249-010-9522-9","article-title":"Validation of a static Franz diffusion cell system for in vitro permeation studies","volume":"11","author":"Ng","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0250","article-title":"Toxic effect of vancomycin on viability and functionality of different cells involved in tissue regeneration","volume":"9","author":"Braun","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jor.2018.01.032","article-title":"Topical vancomycin and its effect on survival and migration of osteoblasts, fibroblasts, and myoblasts: an in vitro study","volume":"15","author":"Liu","year":"2018","journal-title":"J. Orthop."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14444\/4012","article-title":"The effects of topical vancomycin on mesenchymal stem cells: more may not be better","volume":"11","author":"Chu","year":"2017","journal-title":"Int. J. Spine Surg."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0265","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1592\/phco.26.9.1320","article-title":"Society of infectious diseases, application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists","volume":"26","author":"Lodise","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0270","series-title":"Human Skin Cancers","article-title":"Correlation between porcine and human skin models by optical methods","author":"Fujita","year":"2018"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0275","first-page":"163","article-title":"Skin models for the testing of transdermal drugs","volume":"8","author":"Abd","year":"2016","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11095-007-9429-7","article-title":"In vivo methods for the assessment of topical drug bioavailability","volume":"25","author":"Herkenne","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0285","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpha.2014.07.007","article-title":"Development and validation of microbial bioassay for quantification of levofloxacin in pharmaceutical preparations","volume":"5","author":"Dafale","year":"2015","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0290","first-page":"753","article-title":"A fully validated microbiological assay to evaluate the potency of ceftriaxone sodium, Brazilian","volume":"49","author":"Manfio","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0295","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1136\/ejhpharm-2018-001699","article-title":"Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS yellow cover document compliance for continuous infusions in an outpatient setting","volume":"27","author":"Jamieson","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0300","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0018578718779009","article-title":"Stability of Meropenem after reconstitution for administration by prolonged infusion","volume":"54","author":"Fawaz","year":"2019","journal-title":"Hosp. Pharm."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2023.12.008_bb0305","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0310","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.drudis.2020.11.004","article-title":"Oral meropenem for superbugs: challenges and opportunities","volume":"26","author":"Raza","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120663","article-title":"Transdermal delivery of vancomycin hydrochloride: influence of chemical and physical permeation enhancers","volume":"602","author":"Datta","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0320","doi-asserted-by":"crossref","first-page":"2001307","DOI":"10.1002\/admt.202001307","article-title":"Vancomycin-loaded microneedle arrays against methicillin-resistant staphylococcus aureus skin infections","volume":"6","author":"Ziesmer","year":"2021","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0325","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.eimc.2015.10.012","article-title":"Evaluation of the tissue diffusion capacity of antibiotics in lower limb ischaemia","volume":"34","author":"Lozano-Alonso","year":"2016","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0330","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fcimb.2017.00404","article-title":"A novel 3D skin explant model to study anaerobic bacterial infection","volume":"7","author":"Maboni","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0335","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1128\/CMR.14.2.244-269.2001","article-title":"Wound microbiology and associated approaches to wound management","volume":"14","author":"Bowler","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0340","series-title":"Center for Drug Evaluation and Research (CDER)","article-title":"Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment","author":"Guidance for Industry","year":"2013"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2023.12.008_bb0345","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/590064","article-title":"Pharmacokinetic and pharmacodynamic properties of meropenem","volume":"47","author":"Nicolau","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0350","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1128\/AAC.02714-15","article-title":"Vancomycin 24-hour area under the curve\/minimum bactericidal concentration ratio as a novel predictor of mortality in methicillin-resistant Staphylococcus aureus bacteremia","volume":"60","author":"Britt","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0355","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0360","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0365","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/978-1-62703-050-2_21","article-title":"Mechanism-based pharmacodynamic modeling","volume":"929","author":"Felmlee","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00476-17","article-title":"In vivo pharmacokinetics and pharmacodynamics of ZTI-01 (Fosfomycin for injection) in the neutropenic murine thigh infection model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa","volume":"61","author":"Lepak","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0375","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1128\/AAC.49.12.4920-4927.2005","article-title":"Optimization of meropenem minimum concentration\/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa","volume":"49","author":"Tam","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0380","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.addr.2021.04.005","article-title":"Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms","volume":"174","author":"Birk","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0385","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/iwj.12142","article-title":"Antimicrobial dressing efficacy against mature Pseudomonas aeruginosa biofilm on porcine skin explants","volume":"12","author":"Phillips","year":"2015","journal-title":"Int. Wound J."},{"issue":"S8","key":"10.1016\/j.jconrel.2023.12.008_bb0390","first-page":"S10","article-title":"Biofilm in wound care","volume":"S6","author":"Rajpaul","year":"2015","journal-title":"Br. J. Commun. Nurs. Suppl. Wound. Care"},{"key":"10.1016\/j.jconrel.2023.12.008_bb0395","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fmicb.2019.00913","article-title":"Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents-how P. Aeruginosa can escape antibiotics","volume":"10","author":"Ciofu","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0400","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jphsr\/rmab036","article-title":"Impact of pharmacist-led services on antimicrobial stewardship programs: a meta-analysis on clinical outcomes","volume":"12","author":"Mahmood","year":"2021","journal-title":"J. Pharm. Health Serv. Res."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0405","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1017\/ice.2020.1275","article-title":"Outcomes of an ambulatory care pharmacist-led antimicrobial stewardship program within a family medicine resident clinic","volume":"42","author":"Westerhof","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.jconrel.2023.12.008_bb0410","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/S2666-5247(22)00121-5","article-title":"Research priorities towards precision antibiotic therapy to improve patient care","volume":"3","author":"Bulman","year":"2022","journal-title":"Lancet Microbe"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:58:03Z","timestamp":1759165083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923007927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":82,"alternative-id":["S0168365923007927"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of antibiotic release and antibacterial efficacy from pendant glutathione hydrogels using ex vivo porcine skin","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}